Obexelimab, Placebo sterile solution for SC injection clinical trials

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, WITH A SAFETY AND DOSE CONFIRMATION RUN-IN PERIOD, TO EVALUATE THE EFFICACY AND SAFETY OF OBEXELIMAB IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA (SAPHIARE)

This study is testing a new medicine called Obexelimab for people with Warm Autoimmune Hemolytic Anemia (wAIHA). It wants to see if the medicine is safe and helps improve their red blood cell levels compared to a dummy treatment.